Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Inventory: 2014-2025

Historic Inventory for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $92.3 million.

  • Surgery Partners' Inventory rose 1256.1% to $92.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $92.3 million, marking a year-over-year increase of 1256.1%. This contributed to the annual value of $88.4 million for FY2024, which is 1755.32% up from last year.
  • Per Surgery Partners' latest filing, its Inventory stood at $92.3 million for Q3 2025, which was up 1256.1% from $87.3 million recorded in Q2 2025.
  • Surgery Partners' Inventory's 5-year high stood at $92.3 million during Q3 2025, with a 5-year trough of $56.1 million in Q1 2021.
  • Moreover, its 5-year median value for Inventory was $71.4 million (2022), whereas its average is $72.8 million.
  • Its Inventory has fluctuated over the past 5 years, first soared by 116.62% in 2023, then surged by 1815.56% in 2024.
  • Over the past 5 years, Surgery Partners' Inventory (Quarter) stood at $61.1 million in 2021, then rose by 16.86% to $71.4 million in 2022, then grew by 5.32% to $75.2 million in 2023, then increased by 17.55% to $88.4 million in 2024, then grew by 4.41% to $92.3 million in 2025.
  • Its last three reported values are $92.3 million in Q3 2025, $87.3 million for Q2 2025, and $88.1 million during Q1 2025.